MODULATION BY RETINOIC ACID (RA) OF SQUAMOUS-CELL DIFFERENTIATION, CELLULAR RA-BINDING PROTEINS, AND NUCLEAR RA RECEPTORS IN HUMAN HEAD ANDNECK SQUAMOUS-CELL CARCINOMA CELL-LINES
Cp. Zou et al., MODULATION BY RETINOIC ACID (RA) OF SQUAMOUS-CELL DIFFERENTIATION, CELLULAR RA-BINDING PROTEINS, AND NUCLEAR RA RECEPTORS IN HUMAN HEAD ANDNECK SQUAMOUS-CELL CARCINOMA CELL-LINES, Cancer research, 54(20), 1994, pp. 5479-5487
The ability of all-trans-retinoic acid (RA) to modulate the growth and
squamous differentiation of four head and neck squamous cell carcinom
a cell lines (183, 886, 1483, and SqCC/Y1) was examined, and the relat
ionship of their state of squamous differentiation and RA responsivene
ss to the expression of cytosolic RA-binding proteins (CRABPs), nuclea
r RA receptors (RARs), and retinoid X receptors (RXRS) was investigate
d. RA inhibited proliferation of all but the 183 cell line and suppres
sed squamous differentiation markers K1 keratin, type 1 transglutamina
se, and involucrin mRNAs and proteins to varying degrees in 183, 1483,
and SqCC/Y1 cells. Traces of CRABP-I mRNA were detected only in the 8
86 cells, whereas CRABP-II mRNA was detected in the other three cell l
ines. RA suppressed CRABP-II expression in SqCC/Y1 cells but had no ef
fect on its expression in the other cell lines. All cell lines express
ed mRNAs for RAR-alpha, RAR-beta, RAR-gamma, and RXR-alpha. The RAR-be
ta mRNA level was lowest in the SqCC/Y1 cells, and RXR-beta and RXR-ga
mma were not detected in any of the cell lines. RA treatment increased
the levels of the three RAR mRNAs in most of the cell lines but had n
o effect on the RXR mRNAs. The CRABP-II mRNA level in SqCC/Y1 cells wa
s lowest in cells grown in serum-free medium and increased when the ce
lls were grown in medium with 5 or 10% serum. In contrast, the RXR-alp
ha mRNA level was inversely related to serum concentration. The result
s show that, in head and neck squamous cell carcinoma cells, there are
no simple relationships among the expression of CRABPs, RARs, and RXR
s and either squamous differentiation or response to RA-induced growth
inhibition or suppression of squamous differentiation.